Germany backs EU recovery fund, Gilead drug flops, Rana Foroohar on US austerity
FT News Briefing
00:00
Intro
This chapter explores Germany's role in proposing a recovery fund for Eurozone nations affected by COVID-19, along with the differing opinions on fund allocation amongst European leaders. It also addresses the impact of disappointing COVID-19 treatment results from Gilead Sciences on the stock market.
Play episode from 00:00
Transcript
